IDiyas

For the Inventor, By the Inventor

Barcelona, Spain

Antoni Torrens Jover

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Barcelona, ES (2005 - 2014)
  • Terrasa-Barcelona, ES (2015)
  • Terrassa, ES (2006 - 2016)

Company Filing History:

goldMedal13 out of 150 
 
Laboratorios Del Dr. Esteve S.a.
 patents
silverMedal3 out of 23 
 
Laboratories Del Dr. Esteve S.a.
 patents
bronzeMedal2 out of 2 
 
Esteve Laboratorios Dr. Esteve S.a.
 patents

Years Active: 2005-2016

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 9518015 - EP1 receptor ligands (2016-12-13),
2. 9181195 - Sigma receptor inhibitors (2015-11-10),
3. 8729073 - 5-methyl-1-(naphthalen-2-yl)-1H-pyrazole derivatives and their use in potentiating the effect of opioid analgesics (2014-05-20),
4. 8492425 - 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors (2013-07-23),
5. 8329880 - Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors (2012-12-11),
6. 8188115 - [object Object] (2012-05-29),
7. 8148397 - 5-HT7 receptor antagonists (2012-04-03),
8. 7928121 - 5-HT7 receptor antagonists (2011-04-19),
9. 7662862 - [object Object] (2010-02-16),
10. 7553965 - [object Object] (2009-06-30),
11. 7514429 - Benzoxazinone-derived compounds, their preparation and use as medicaments (2009-04-07),
12. 7345057 - 5-HT7 receptor antagonists (2008-03-18),
13. 7211585 - [object Object] (2007-05-01),
14. 7211584 - 5-HT7 receptor ligands (2007-05-01),
15. 7109349 - Process for obtaining Cizolirtine and its enantiomers (2006-09-19),

Title: The Innovative Contributions of Antoni Torrens Jover

Introduction

Antoni Torrens Jover is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of medicinal chemistry, particularly through his work on receptor ligands. With a total of 18 patents to his name, Jover's innovations have the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents, Jover has developed EP1 receptor ligands. This invention pertains to compounds with a general formula (I) that exhibit high affinity and selectivity for the EP1 receptor. The invention also includes the processes for their preparation and their application as medicaments for treating diseases mediated by the EP1 receptor. Additionally, he has worked on sigma receptor inhibitors, which are compounds that demonstrate pharmacological activity towards the sigma receptor. This patent encompasses the preparation processes, pharmaceutical compositions, and their use in treating diseases associated with the sigma receptor.

Career Highlights

Throughout his career, Antoni Torrens Jover has been associated with notable companies, including Laboratorios Del Dr. Esteve S.A. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Jover has collaborated with esteemed colleagues such as Alberto Dordal Zueras and Helmut Heinrich Buschmann. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Antoni Torrens Jover's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…